Chronic health consequences of the COVID-19 pandemic on school workers: a cross-sectional post-pandemic analysis.

Publication date: Jul 28, 2025

The COVID-19 pandemic dramatically affected schools. However, there are insufficient data on the chronic physical and mental health consequences of the pandemic in school workers. To determine the prevalence and the functional and mental health impact of pandemic-related chronic health symptoms among school workers towards the end of the COVID-19 pandemic. Cross-sectional analysis of health questionnaires and serology testing data (nucleocapsid, N antibodies) collected between January and April 2023, within a cohort of school workers. Three large school districts (Vancouver, Richmond, Delta) in the Vancouver metropolitan area, Canada (representing 186 elementary and secondary schools in total). Active school staff employed in these three school districts. COVID-19 infection history by self-reported viral and/or nucleocapsid antibody testing. Self-reported, new-onset pandemic-related chronic health symptoms that started within the past year, lasting at least 3 months, after a positive viral test among those with a known infection. Of 1128 school staff enrolled from 185/186 (99. 5%) schools, 1086 (96. 3%) and 998 (88. 5%) staff completed health questionnaires and serology testing, respectively. The N-seroprevalence adjusted for clustering by school and test sensitivity and specificity was 84. 7% (95% Credible Interval (95% CrI): 79. 2% to 91. 8%) compared with 85. 4% (95% CrI: 81. 6% to 90. 3%) in a community-matched sample of blood donors. Overall, 31. 1% (95% CI: 28. 4% to 34. 0%) staff reported new-onset chronic symptoms. These symptoms were more frequently reported in staff with viral test-confirmed infections (38. 0% (95% CI: 34. 3% to 41. 9%)) compared with those with positive serology who were unaware that they had COVID-19 (14. 3% (95% CI: 7. 6% to 23. 6%); p

Open Access PDF

Concepts Keywords
April COVID-19
Canada Health
Pandemic Post-Acute COVID-19 Syndrome
Viral Schools

Semantics

Type Source Name
disease MESH COVID-19 pandemic
drug DRUGBANK Etoperidone
disease MESH infection
disease IDO history
disease IDO blood
disease MESH Post-Acute COVID-19 Syndrome

Original Article

(Visited 2 times, 1 visits today)